Harmonization Of Health Technology Assessment Across The European Union: Lessons For The United States

Public insurance programs and private insurance plans must develop criteria for deciding which drugs to cover, for which patients, and under which conditions. For this they need to assess the incremental clinical and social contribution of new products and compare them to the products already on the market. These assessments then must be weighed against the incremental spending likely to be incurred. Implicitly, if not explicitly, insurers must conduct a health technology assessment (HTA).

In the multi-payer US system, each public program, private insurer, and self-insured employer conducts its own assessments. Most are done without explicit attention to the quality of the evidence and without providing the documentation that would be needed for stakeholders to understand what has been...

Today's Sponsors

Today's Sponsor